Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study
2012 ◽
Vol 91
(6)
◽
pp. 540-546
◽
2019 ◽
Vol 63
(6)
◽
pp. 437-447
◽
Keyword(s):
2005 ◽
Vol 15
(1)
◽
pp. 74-80
◽
2006 ◽
Vol 90
(5)
◽
pp. 593-596
◽
2004 ◽
Vol 111
(11)
◽
pp. 1981-1992.e1
◽
2016 ◽
Vol 255
(3)
◽
pp. 475-484
◽
2008 ◽
Vol 17
(4)
◽
pp. 559-574
◽